Adhera Therapeutics, Inc. Security Agreements

21 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Security Agreement among Adhera Therapeutics, Inc., Subsidiaries, and Noteholders
Security Agreements
Adhera Therapeutics, Inc.
Biotechnology
2023
Security Agreement among Adhera Therapeutics, Inc., Subsidiaries, and Holders of Senior Secured Promissory Notes
Security Agreements
Adhera Therapeutics, Inc.
Biotechnology
2023
Security Agreement among Adhera Therapeutics, Inc., Subsidiaries, and Holders of Senior Secured Promissory Notes
Security Agreements
Adhera Therapeutics, Inc.
Biotechnology
2023
Security Agreement among Adhera Therapeutics, Inc., Subsidiaries, and Noteholders
Security Agreements
Adhera Therapeutics, Inc.
Biotechnology
2023
Security Agreement among Adhera Therapeutics, Inc., Subsidiaries, and Holders of Senior Secured Promissory Notes
Security Agreements
Adhera Therapeutics, Inc.
Biotechnology
2023
Security Agreement among Adhera Therapeutics, Inc., Subsidiaries, and Noteholders
Security Agreements
Adhera Therapeutics, Inc.
Biotechnology
2023
Security Agreement among Adhera Therapeutics, Inc., Subsidiaries, and Holders of Senior Secured Promissory Notes (May 2022)
Security Agreements
Adhera Therapeutics, Inc.
Biotechnology
2022
Security Agreement between Adhera Therapeutics, Inc. and Cavalry Fund I LP (June 26, 2020)
Security Agreements
Adhera Therapeutics, Inc.
Biotechnology
NY
2020
Security Agreement among Adhera Therapeutics, Inc., Subsidiaries, and Purchasers, Dated June 28, 2019
Security Agreements
Adhera Therapeutics, Inc.
Biotechnology
NY
2019
Intellectual Property Security Agreement between Marina Biotech, Inc. and River Charitable Remainder Unit Trust
Security Agreements
Adhera Therapeutics, Inc.
Biotechnology
NY
2017
Security Agreement among Marina Biotech, Inc. and Subsidiaries and River Charitable Remainder Unit Trust (2017)
Security Agreements
Adhera Therapeutics, Inc.
Biotechnology
NY
2017
Intellectual Property Security Agreement among Marina Biotech, Inc., Cequent Pharmaceuticals, Inc., MDRNA Research, Inc., and Genesis Capital Management, LLC
Security Agreements
Adhera Therapeutics, Inc.
Biotechnology
DE
2012
Security Agreement among Marina Biotech, Inc., Subsidiaries, and Genesis Capital Management, LLC (as Agent)
Security Agreements
Adhera Therapeutics, Inc.
Biotechnology
NY
2012
Security Agreement (Patents) between MDRNA Research, Inc. and Cequent Pharmaceuticals, Inc.
Security Agreements
Adhera Therapeutics, Inc.
Biotechnology
2010
Security Agreement (Patents) between MDRNA, Inc. and Cequent Pharmaceuticals, Inc.
Security Agreements
Adhera Therapeutics, Inc.
Biotechnology
2010
Security Agreement (All Assets) between MDRNA, Inc., Subsidiaries, and Cequent Pharmaceuticals, Inc. dated March 31, 2010
Security Agreements
Adhera Therapeutics, Inc.
Biotechnology
MA
2010
Addendum to Security Agreement: Securities Account between Nastech Pharmaceutical Company Inc. and Wells Fargo Bank
Security Agreements
Adhera Therapeutics, Inc.
Biotechnology
2004
Securities Account Control Agreement among Nastech Pharmaceutical, Wells Fargo (Intermediary), and Wells Fargo (Secured Party) dated December 19, 2003
Security Agreements
Adhera Therapeutics, Inc.
Biotechnology
DE
2004
Addendum to Security Agreement: Securities Account between Nastech Pharmaceutical Company Inc. and Wells Fargo Bank
Security Agreements
Adhera Therapeutics, Inc.
Biotechnology
2003
Security Agreement between Nastech Pharmaceutical Company Inc. and Wells Fargo Bank, N.A. (Securities Account Collateral)
Security Agreements
Adhera Therapeutics, Inc.
Biotechnology
DE
2003
Security Agreement between Nastech Pharmaceutical Company, Inc. and Schwarz Pharma, Inc. dated September 30, 2002
Security Agreements
Adhera Therapeutics, Inc.
Biotechnology
NY
2002